Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06728228 · ClinicalTrials.gov registry record · NA
Amnioinfusion for Fetal Renal Failure
A NA study of Polycystic Kidney Disease and Lower Urinary Tract Obstructive Syndrome, sponsored by Fetal Care Center, P.
- Recruiting
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 1
- Study location
NCT06728228 is a NA study of Polycystic Kidney Disease and Lower Urinary Tract Obstructive Syndrome that is actively recruiting participants, run by Fetal Care Center, P. The registered enrollment target is 35 participants, below the 326-participant average among 5 other Polycystic Kidney Disease trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06728228, a NA study of Polycystic Kidney Disease and Lower Urinary Tract Obstructive Syndrome, is actively recruiting participants, sponsored by Fetal Care Center, P.
- RECRUITING
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn if serial amnioinfusions can improve the chances of survival for fetuses with severe kidney problems that cause low amniotic fluid (anhydramnios). Low amniotic fluid can affect lung development and may lead to serious health issues for the fetus. The main questions this study aims to answer are: * Can serial amnioinfusion increase the chances of survival for these fetuses? * Does this procedure improve chances of survival until dialysis and/or kidney transplant? Participants will: * Receive regular amnioinfusions, which is a procedure that adds fluid to the amniotic cavity. * Undergo monitoring to check the effects on the fetus and mother. This study will help researchers understand if amnioinfusion is a useful treatment for fetal kidney problems and may provide valuable information for similar cases in the future.
Conditions Studied
Interventions
- OTHER Amnioinfusion
Study Locations (1)
Texas
- Fetal Care Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2024-12-05 |
| Est. Completion | 2026-11-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06728228
The ClinicalTrials.gov registry entry for NCT06728228 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 326-participant average among 5 other Polycystic Kidney Disease trials with a reported enrollment target (89% lower). The listed sponsor is Fetal Care Center, P, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 9 conditions, with Polycystic Kidney Disease appearing as the primary indexed condition, and to 1 intervention - of which Amnioinfusion is the first listed.
NCT06728228 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06728228 about?
NCT06728228 is a clinical study titled "Amnioinfusion for Fetal Renal Failure". The goal of this clinical trial is to learn if serial amnioinfusions can improve the chances of survival for fetuses with severe kidney problems that cause low amniotic fluid (anhydramnios). Low amniotic fluid can affect lung development and may lead to serious health issues for the fetus. The main ...
What is the current status of trial NCT06728228?
This trial is currently recruiting. It is a NA study. The enrollment target is 35 participants. The study started on 2024-12-05. Estimated completion is 2026-11-15.
What conditions does trial NCT06728228 study?
This clinical trial studies the following conditions: Polycystic Kidney Disease, Lower Urinary Tract Obstructive Syndrome, Multicystic Dysplastic Kidney, Fetal Renal Anomaly, Anhydramnios.
What interventions are being tested in trial NCT06728228?
The interventions under investigation include: Amnioinfusion (OTHER).
Who is sponsoring clinical trial NCT06728228?
This trial is sponsored by Fetal Care Center, P, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06728228 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Polycystic Kidney Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Well-Formulated Ketogenic Diet Polycystic Kidney Disease
RECRUITING · NA
-
PKD Clinical and Translational Core Study
RECRUITING
-
Polycystic Kidney Disease Data Repository
RECRUITING
-
Early PKD Observational Cohort Study
RECRUITING
-
Uncontrolled, Open Label, Pilot and Feasibility Study of Niacinamide in Polycystic Kidney Disease
COMPLETED · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.